|
Volumn 36, Issue 4, 2001, Pages 429-433
|
Effects of high-dose methotrexate on the hemostatic system in childhood acute lymphoblastic leukemia
|
Author keywords
Acute lymphoblastic leukemia; Asparaginase; Childhood cancer; Hemostatic system; Methotrexate
|
Indexed keywords
ANTITHROMBIN III;
ASPARAGINASE;
BICARBONATE;
BLOOD CLOTTING INHIBITOR;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DAUNORUBICIN;
ETOPOSIDE;
FIBRIN DEGRADATION PRODUCT;
FIBRINOGEN;
FLUOROURACIL;
FOLINIC ACID;
METHOTREXATE;
PREDNISOLONE;
PROTEIN C;
PROTEIN S;
TISSUE PLASMINOGEN ACTIVATOR;
VINCRISTINE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADOLESCENT;
ARTICLE;
BLOOD CLOTTING TEST;
CANCER COMBINATION CHEMOTHERAPY;
CHILD;
CHILDHOOD CANCER;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG EFFECT;
DRUG INDUCED DISEASE;
DRUG MEGADOSE;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
MALE;
NEUTROPENIA;
PARTIAL THROMBOPLASTIN TIME;
PRIORITY JOURNAL;
PROTHROMBIN TIME;
TREATMENT OUTCOME;
ADOLESCENT;
ANTIMETABOLITES, ANTINEOPLASTIC;
BLOOD COAGULATION DISORDERS;
BLOOD COAGULATION FACTOR INHIBITORS;
BLOOD COAGULATION FACTORS;
BLOOD COAGULATION TESTS;
CHILD;
CHILD, PRESCHOOL;
FEMALE;
HEMOSTASIS;
HUMANS;
LEUKEMIA, LYMPHOCYTIC, ACUTE;
MALE;
METHOTREXATE;
MULTIVARIATE ANALYSIS;
|
EID: 0035079642
PISSN: 00981532
EISSN: None
Source Type: Journal
DOI: 10.1002/mpo.1106 Document Type: Article |
Times cited : (15)
|
References (27)
|